R T D'Aquila

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint CCR5/delta(ccr5) heterozygosity: a selective pressure for the syncytium-inducing human immunodeficiency virus type 1 phenotype. NIAID AIDS Clinical Trials Group Protocol 241 Virology Team
    R T D'Aquila
    Massachusetts General Hospital, Harvard Medical School, Boston, USA
    J Infect Dis 177:1549-53. 1998
  2. ncbi request reprint Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel
    M S Hirsch
    Harvard Medical School, Boston, MA, USA
    JAMA 279:1984-91. 1998
  3. ncbi request reprint Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel
    M S Hirsch
    Harvard Medical School, Boston, Mass, USA
    JAMA 283:2417-26. 2000
  4. pmc Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1
    J Martinez-Picado
    Infectious Disease Unit and AIDS Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    J Virol 73:3744-52. 1999
  5. ncbi request reprint Human immunodeficiency virus type 1 hypersusceptibility to amprenavir in vitro can be associated with virus load response to treatment in vivo
    K C Zachary
    Infectious Disease Division, Massachusetts General Hospital, Partners AIDS Research Center, and Harvard Medical School, Boston, MA 02114, USA
    Clin Infect Dis 33:2075-7. 2001
  6. ncbi request reprint Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens
    P B Gilbert
    Center for Biostatistics in AIDS Research and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    AIDS Res Hum Retroviruses 16:1325-36. 2000

Collaborators

Detail Information

Publications6

  1. ncbi request reprint CCR5/delta(ccr5) heterozygosity: a selective pressure for the syncytium-inducing human immunodeficiency virus type 1 phenotype. NIAID AIDS Clinical Trials Group Protocol 241 Virology Team
    R T D'Aquila
    Massachusetts General Hospital, Harvard Medical School, Boston, USA
    J Infect Dis 177:1549-53. 1998
    ....
  2. ncbi request reprint Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel
    M S Hirsch
    Harvard Medical School, Boston, MA, USA
    JAMA 279:1984-91. 1998
    ..To review current knowledge of the biology and clinical implications of human immunodeficiency virus (HIV) resistance to antiretroviral drugs, describe assays for measuring resistance, and assess their use in clinical practice...
  3. ncbi request reprint Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel
    M S Hirsch
    Harvard Medical School, Boston, Mass, USA
    JAMA 283:2417-26. 2000
    ..The International AIDS Society-USA sought to update prior recommendations to provide guidance for clinicians regarding indications for HIV-1 resistance testing...
  4. pmc Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1
    J Martinez-Picado
    Infectious Disease Unit and AIDS Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    J Virol 73:3744-52. 1999
    ....
  5. ncbi request reprint Human immunodeficiency virus type 1 hypersusceptibility to amprenavir in vitro can be associated with virus load response to treatment in vivo
    K C Zachary
    Infectious Disease Division, Massachusetts General Hospital, Partners AIDS Research Center, and Harvard Medical School, Boston, MA 02114, USA
    Clin Infect Dis 33:2075-7. 2001
    ..We report a case of N88S developing after virologic failure of both indinavir- and nelfinavir-containing regimens that was managed successfully with a regimen that contained amprenavir...
  6. ncbi request reprint Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens
    P B Gilbert
    Center for Biostatistics in AIDS Research and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    AIDS Res Hum Retroviruses 16:1325-36. 2000
    ....